Boston, MA

Cancer Medicine
& Hematology

23 - 28 September 2018
The Fairmont Copley Plaza Hotel
Boston, MA

Offered By

Dana Farber Partners Cancer Care Dana Farber Partners Cancer Care
Massachusetts General Hospital
Dana Farber Cancer Institute
Brigham and Women's Hospital

Care for patients with solid tumors, hematologic malignancies, and benign hematologic disorders continues to evolve with the development of novel therapeutic agents and testing modalities, accumulation of clinical trial data, and ongoing revisions to expert guidelines.

Oncologists, hematologists, and other clinicians who participate in the care of patients with these disorders are challenged to stay current on the latest diagnosis, treatment, and management advances.

Cancer Medicine and Hematology is an intensive six-day course provides a comprehensive review of the clinical, molecular, and pathophysiologic basis for the diagnosis and treatment of neoplastic diseases and benign hematologic conditions.

Primary emphasis will be placed upon the broad area of medical management within a multidisciplinary environment. Recent advances in molecular genetics, clinical pharmacology, epidemiology, and supportive care will be stressed.

This course will engage participants in lectures using an audience response system as well as interactive panels and case discussions.

Dr Robert Mayer, MD
Course Director
Robert J. Mayer, MD

Learner Objectives

Upon completion of this course participants will be able to:

  • Use current expert recommendations to select management approaches to benign hematologic disorders, incorporating new clinical evidence and new therapies as they emerge
  • Apply recent advances in molecular testing for diagnosis, risk assessment, and disease monitoring to the selection of current and emerging systemic therapies and overall management approaches in patients with hematologic malignancies
  • Incorporate new therapies and emerging management strategies into current multimodal treatment regimens for patients with gastrointestinal cancers, including hereditary cancers
  • Select individualized treatment approaches for patients with gynecologic cancers that consider recent clinical data on the role of molecular characteristics of these tumors
  • Use molecular and histopathologic characteristics to select appropriate systemic therapies for patients with head, neck, and lung cancers
  • Apply current and emerging clinical evidence to the individualized selection of multimodal treatment approaches for patients with genitourinary cancers
  • Recognize current subtype-specific standards of care for breast cancer and incorporating new clinical data and new therapies as they become available
  • Incorporate new clinical data on treatment advances into current treatment paradigms for a wide range of additional malignancies, including melanoma, thyroid, neuroendocrine, central nervous system, and other types of cancers

Target Audience

The target audience for Cancer Medicine and Hematology 2018 consists of medical oncologists, hematologists, radiation oncologists, oncology surgeons, internal medicine physicians, oncology fellows, physician assistants, and advanced practice nurses who focus on oncology and hematology.

Credit Information


This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Dana-Farber Cancer Institute. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 45 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 45 points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion data to ACCME for the purpose of granting ABIM MOC credit.

While offering credits noted above, the course is not intended to provide extensive training or certification in the field.


The Fairmont Copley Plaza Hotel
Boston, MA

The meeting will be held at the Fairmont Copley Plaza, 138 St. James Avenue, Boston, MA 02116.

The room block has expired, however, a small number of rooms are still available.

To secure your lodging, please use the phone number provided below.

Call: 800-441-1414

Do not arrange your accommodations until you have registered and received your registration confirmation.

Fairmont Copley Plaza exterior
Fairmont Copley Plaza interior

Course schedule

“Excellent comprehensive review and update. I was able to achieve a 360° view on the current status of clinical oncology”
- 2017 Course Attendee


“Having access to such accomplished speakers was what set this apart from other programs.”
2017 Course Attendee

Purchase online materials

Online Course Materials

Unable to attend?

If you’re unable to attend the course in Boston, you have the opportunity to purchase online access to the presentation materials in pdf format for $300.00

Want the printed syllabus as well?

Just add it on to your order for an additional $250.00.

Please allow 2 weeks for printed materials to be delivered

Add printed syllabus

No Yes

Your order is ready to be placed. Choose the Checkout button below to begin your order.


Terms & conditions

Please do not purchase nonrefundable airline ticket(s) until you have received an email from our office confirming your paid registration.

Refunds, less an administrative fee of $50, will be issued for all cancellations received two weeks prior to the start of the course.

Refunds, less an administrative fee of $100, will be issued for all cancellations occurring less than two weeks prior to the start of the course.

“No shows” are subject to the full course fee and no refunds will be issued once the conference has started.

© 2018 Cancer Medicine & Hematology. All rights reserved.